Stability Studies

From protocol to reporting, our stability studies support confident shelf‑life assignment.

stability studies - Copy

Shelf‑life supported by stability data

Long-term and accelerated stability programs designed to produce regulatory‑ready data.

Stability studies demonstrate how a drug product’s quality changes over time under defined environmental and physical conditions, generating the evidence used to support shelf life and storage expectations.

At Groupe PARIMA, stability testing is performed in-house and is integrated with long-term and accelerated stability activities within formulation development, scale-up, and commercial manufacturing.

Stability Conditions
by Target Market

We run ICH‑aligned standard conditions, plus cold‑chain and specialized studies, to match your product’s storage, distribution, and target markets.

long term-

Long‑Term

25°C / 60% RH long‑term studies generate the core data package used to support shelf life and labeled storage conditions for temperate markets.

intermediate - Copy

Intermediate

30 °C / 65% RH intermediate studies are conducted only if a significant change occurs at accelerated conditions, to provide reliable support for shelf‑life.

zone IV-B - Copy

Zone IV‑B

30°C / 75% RH supports programs intended for hot/high‑humidity regions, defined as a long‑term condition.

accelerated - Copy

Accelerated

40°C / 75% RH accelerated studies help characterize stability trends earlier and support risk‑based decisions during development and registration planning.

cold chain - Copy

Cold‑Chain

Cold condition studies (2–8 °C) demonstrate stability for products intended for refrigerated storage, where higher temperatures would accelerate degradation without reflecting actual use conditions.

frozen conditions

Frozen Conditions

−20°C conditions are available for highly sensitive products requiring frozen storage, to prevent degradation or maintain stability that cannot be achieved at higher temperatures.

Stability studies at Groupe PARIMA support confident shelf‑life decisions through controlled, specification‑driven testing across defined storage conditions.

Resources

Access stability insights and guidance to support shelf‑life, storage conditions, and lifecycle decisions.

White papers
2026/07/06
How Drug Product Formulation Works: Topical, Oral, and Nasal Liquid and Semi-Solid Dosage Forms
White papers
2026/07/03
How Early API Characterization Can Reduce Formulation and Scale-up Risks
White papers
2026/07/06
How Drug Product Formulation Works: Topical, Oral, and Nasal Liquid and Semi-Solid Dosage Forms
White papers
2026/07/03
How Early API Characterization Can Reduce Formulation and Scale-up Risks

Contact us

Stability test you can trust.

Let’s review your stability protocol, target markets, and packaging to generate regulatory‑ready data across defined storage conditions.